Verve Therapeutics Inc - Received First Milestone Payment From Eli Lilly for Collaboration on in Vivo Gene Editing Program Targeting Lipoprotein(a)
Verve Therapeutics Inc-因合作開展針對脂蛋白(a)的體內基因編輯計劃而獲得禮來公司的第一筆里程碑式付款
Verve Therapeutics Inc - Received First Milestone Payment From Eli Lilly for Collaboration on in Vivo Gene Editing Program Targeting Lipoprotein(a)
Verve Therapeutics Inc-因合作開展針對脂蛋白(a)的體內基因編輯計劃而獲得禮來公司的第一筆里程碑式付款
使用瀏覽器的分享功能,分享給你的好友吧